Cathie Wood Purple Biotech Ltd. Transaction History

Ark Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$2.45 - $4.3 $1.62 Million - $2.85 Million	-662,499 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$3.75 - $4.67 $275,700 - $343,338	-73,520 Reduced 9.99%	662,499 $2.58 Million
Q3 2021 Nov 12, 2021	BUY	$4.4 - $5.59 $3.24 Million - $4.11 Million	736,019 New	736,019 $3.37 Million

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $46.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.